A multicentre molecular analysis of hepatitis B and blood-borne virus coinfections in Viet Nam

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Dunford, Linda ^a,b,c   Carr, Michael J ^a,b,c   Dean, Jonathan ^a,b,c   Nguyen, Linh Thuy ^a,b,d   Ta Thi, Thu Hong ^a,b,d   Nguyen, Binh Thanh ^a,b,d   Connell, Jeff ^a,b,c   Coughlan, Suzie ^a,b,c   Nguyen, Hien Tran ^a,b,d   Hall, William W ^a,b,c   Thi, Lan Anh Nguyen ^a,b,d  

^a Ireland Vietnam Blood Borne Virus Initiative (IVVI)   (Ireland)

^b University College Dublin ^*

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

^d National Institute of Hygiene and Epidemiology   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; INTERLEUKIN 28B;

ADOLESCENT; ADULT; ANTIVIRAL RESISTANCE; ARTICLE; DELTA AGENT HEPATITIS; FEMALE; GENE LOCUS; GENETIC VARIABILITY; GENOTYPE; HEMODIALYSIS PATIENT; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTERLEUKIN 28B GENE; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; POINT MUTATION; PREVALENCE; PROSTITUTION; SEROEPIDEMIOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; UNINDEXED SEQUENCE; VIET NAM; VIRUS INFECTION; VIRUS LOAD;

BLOOD-BORNE PATHOGENS; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; MUTATION; PHYLOGENY; POLYMERASE CHAIN REACTION; VIETNAM; VIRAL LOAD;

EID: 84862198002     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039027     Document Type: Article

References (74)

1. World Health Organisation (2009) Hepatitis B vaccines. Weekly epidemiological record/Health Section of the Secretariat of the League of Nations 84: 405-419.
2. Alter MJ, (2003) Epidemiology of hepatitis B in Europe and worldwide. Journal of hepatology 39: S64-69.
3. Lavanchy D, (2004) Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. Journal of viral hepatitis 11: 97-107.
4. Nguyen VT, Law MG, Dore GJ, (2008) An enormous hepatitis B virus-related liver disease burden projected in Vietnam by 2025. Liver international: official journal of the International Association for the Study of the Liver 28: 525-531.
5. Tran VB, Buu M, Nguyen thi M, Morris GE, (1993) Hepatitis B in Ho Chi Minh City, Viet Nam. Transactions of the Royal Society of Tropical Medicine and Hygiene 87: 262.
6. Nakata S, Song P, Duc DD, Nguyen XQ, Murata K, et al. (1994) Hepatitis C and B virus infections in populations at low or high risk in Ho Chi Minh and Hanoi, Vietnam. Journal of Gastroenterology and Hepatology 9: 416-419.
7. Song P, Duc DD, Hien B, Nakata S, Chosa T, et al. (1994) Markers of hepatitis C and B virus infections among blood donors in Ho Chi Minh City and Hanoi, Vietnam. Clinical and diagnostic laboratory immunology 1: 413-418.
8. Katelaris PH, Robertson G, Bradbury R, Tippett G, Hoa DQ, et al. (1995) Seroprevalence of hepatitis viruses in children in rural Viet Nam. Transactions of the Royal Society of Tropical Medicine and Hygiene 89: 487.
9. Kakumu S, Sato K, Morishita T, Trinh KA, Nguyen HB, et al. (1998) Prevalence of hepatitis B, hepatitis C, and GB virus C/hepatitis G virus infections in liver disease patients and inhabitants in Ho Chi Minh, Vietnam. Journal of medical virology 54: 243-248.
10. Hipgrave DB, Nguyen TV, Vu MH, Hoang TL, Do TD, et al. (2003) Hepatitis B infection in rural Vietnam and the implications for a national program of infant immunization. The American journal of tropical medicine and hygiene 69: 288-294.
11. Nguyen VT, McLaws ML, Dore GJ, (2007) Highly endemic hepatitis B infection in rural Vietnam. Journal of Gastroenterology and Hepatology 22: 2093-2100.
12. Duong TH, Nguyen PH, Henley K, Peters M, (2009) Risk factors for hepatitis B infection in rural Vietnam. Asian Pacific journal of cancer prevention: APJCP 10: 97-102.
13. Nguyen CH, Ishizaki A, Chung PT, Hoang HT, Nguyen TV, et al. (2011) Prevalence of HBV infection among different HIV-risk groups in Hai Phong, Vietnam. Journal of medical virology 83: 399-404.
14. Schaefer S, (2007) Hepatitis B virus taxonomy and hepatitis B virus genotypes. World journal of gastroenterology: WJG 13: 14-21.
15. Hannoun C, Norder H, Lindh M, (2000) An aberrant genotype revealed in recombinant hepatitis B virus strains from Vietnam. The Journal of general virology 81: 2267-2272.
16. Tran TT, Trinh TN, Abe K, (2008) New complex recombinant genotype of hepatitis B virus identified in Vietnam. Journal of virology 82: 5657-5663.
17. Kurbanov F, Tanaka Y, Kramvis A, Simmonds P, Mizokami M, (2008) When should "I" consider a new hepatitis B virus genotype? Journal of virology 82: 8241-8242.
18. Olinger CM, Jutavijittum P, Hubschen JM, Yousukh A, Samountry B, et al. (2008) Possible new hepatitis B virus genotype, southeast Asia. Emerging infectious diseases 14: 1777-1780.
19. Yu H, Yuan Q, Ge SX, Wang HY, Zhang YL, et al. (2010) Molecular and phylogenetic analyses suggest an additional hepatitis B virus genotype "I" PloS one 5: e9297.
20. Fang ZL, Hue S, Sabin CA, Li GJ, Yang JY, et al. (2011) A complex hepatitis B virus (X/C) recombinant is common in Long An county, Guangxi and may have originated in southern China. The Journal of general virology 92: 402-411.
21. Arankalle VA, Gandhe SS, Borkakoty BJ, Walimbe AM, Biswas D, et al. (2010) A novel HBV recombinant (genotype I) similar to Vietnam/Laos in a primitive tribe in eastern India. Journal of viral hepatitis 17: 501-510.
22. Colson P, Roquelaure B, Tamalet C, (2009) Detection of a newly identified hepatitis B virus genotype in southeastern France. Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology 45: 165-167.
23. Osiowy C, Kaita K, Solar K, Mendoza K, (2010) Molecular characterization of hepatitis B virus and a 9-year clinical profile in a patient infected with genotype I. Journal of medical virology 82: 942-948.
24. Tatematsu K, Tanaka Y, Kurbanov F, Sugauchi F, Mano S, et al. (2009) A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J. Journal of virology 83: 10538-10547.
25. Alter MJ, (2006) Epidemiology of viral hepatitis and HIV co-infection. Journal of hepatology 44: S6-9.
26. Zhou YH, Liu FL, Yao ZH, Duo L, Li H, et al. (2011) Comparison of HIV-, HBV-, HCV- and co-infection prevalence between Chinese and Burmese intravenous drug users of the China-Myanmar border region. PloS one 6: e16349.
27. Dean J, Ta Thi TH, Dunford L, Carr MJ, Nguyen LT, et al. (2011) Prevalence of HIV type 1 antiretroviral drug resistance mutations in Vietnam: a multicenter study. AIDS research and human retroviruses 27: 797-801.
28. UNAIDS (2010) United Nations General Assembly Meeting Hanoi: The fourth country report on following up the implementation to the declaration of commitment on HIV and AIDS, Vietnam.
29. Lewden C, Salmon D, Morlat P, Bevilacqua S, Jougla E, (2005) Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. International journal of epidemiology 34: 121-130.
30. Palella FJ, Baker RK, Moorman AC, Chmiel JS, Wood KC, et al.et al. (2006) Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. Journal of acquired immune deficiency syndromes 43: 27-34.
31. Matthews GV, Bartholomeusz A, Locarnini S, Ayres A, Sasaduesz J, et al. (2006) Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy. AIDS 20: 863-870.
32. Yuen MF, Lai CL, (2011) Treatment of chronic hepatitis B: Evolution over two decades. Journal of Gastroenterology and Hepatology 26: 138-143.
33. Rizzetto M, (2009) Hepatitis D: thirty years after. Journal of hepatology 50: 1043-1050.
34. Hughes SA, Wedemeyer H, Harrison PM, (2011) Hepatitis delta virus. Lancet 378: 73-85.
35. Cross TJ, Rizzi P, Horner M, Jolly A, Hussain MJ, et al. (2008) The increasing prevalence of hepatitis delta virus (HDV) infection in South London. Journal of medical virology 80: 277-282.
36. Zachou K, Yurdaydin C, Drebber U, Dalekos GN, Erhardt A, et al. (2010) Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis. Liver international: official journal of the International Association for the Study of the Liver 30: 430-437.
37. Mumtaz K, Ahmed US, Memon S, Khawaja A, Usmani MT, et al. (2011) Virological and clinical characteristics of hepatitis delta virus in South Asia. Virology journal 8: 312.
38. Abbas Z, Jafri W, Raza S, (2010) Hepatitis D: Scenario in the Asia-Pacific region. World journal of gastroenterology: WJG 16: 554-562.
39. Farci P, (2003) Delta hepatitis: an update. Journal of hepatology 39: S212-219.
40. Tran HT, Ushijima H, Quang VX, Phuong N, Li TC, et al. (2003) Prevalence of hepatitis virus types B through E and genotypic distribution of HBV and HCV in Ho Chi Minh City, Vietnam. Hepatology research: the official journal of the Japan Society of Hepatology 26: 275-280.
41. Lin CL, Kao JH, (2011) The clinical implications of hepatitis B virus genotype: Recent advances. Journal of Gastroenterology and Hepatology 26: 123-130.
42. Ding X, Gu H, Zhong ZH, Zilong X, Tran HT, et al. (2003) Molecular epidemiology of hepatitis viruses and genotypic distribution of hepatitis B and C viruses in Harbin, China. Japanese journal of infectious diseases 56: 19-22.
43. Thuy le TT, Ryo H, Van Phung L, Furitsu K, Nomura T, (2005) Distribution of genotype/subtype and mutational spectra of the surface gene of hepatitis B virus circulating in Hanoi, Vietnam. Journal of medical virology 76: 161-169.
44. Truong BX, Seo Y, Yano Y, Ho PT, Phuong TM, et al. (2007) Genotype and variations in core promoter and pre-core regions are related to progression of disease in HBV-infected patients from Northern Vietnam. International journal of molecular medicine 19: 293-299.
45. Nguyen LH, Ha NB, Vutien P, Garcia RT, Trinh HN, et al. (2009) Prevalence of hepatitis B virus genotype B in Vietnamese patients with chronic hepatitis B. Hepatology international.
46. Phung TB, Alestig E, Nguyen TL, Hannoun C, Lindh M, (2010) Genotype X/C recombinant (putative genotype I) of hepatitis B virus is rare in Hanoi, Vietnam-genotypes B4 and C1 predominate. Journal of medical virology 82: 1327-1333.
47. Locarnini SA, Yuen L, (2010) Molecular genesis of drug-resistant and vaccine-escape HBV mutants. Antiviral therapy 15: 451-461.
48. Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, et al. (2009) Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461: 399-401.
49. Martin MP, Qi Y, Goedert JJ, Hussain SK, Kirk GD, et al. (2010) IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection. The Journal of infectious diseases 202: 1749-1753.
50. Li W, Jiang Y, Jin Q, Shi X, Jin J, et al. (2011) Expression and gene polymorphisms of interleukin 28B and hepatitis B virus infection in a Chinese Han population. Liver international: official journal of the International Association for the Study of the Liver 31: 1118-1126.
51. Lampertico P, Vigano M, Cheroni C, Facchetti F, Invernizzi F, et al. (2012) IL28B polymorphisms predict interferon-related HBsAg seroclearance in genotype D HBeAg-negative patients with chronic hepatitis B. Hepatology.
52. Sonneveld MJ, Wong VW, Woltman AM, Wong GL, Cakaloglu Y, et al. (2012) Polymorphisms near IL28B and serologic response to peginterferon in HBeAg-positive patients with chronic hepatitis B. Gastroenterology 142: 513-520 e511.
53. Saulnier P, Vidaud M, Gautier E, Motte N, Bellet D, et al. (2003) Development and validation of a real-time PCR assay for the detection and quantitation of p53 recombinant adenovirus in clinical samples from patients treated with Ad5CMV-p53 (INGN 201). Journal of virological methods 114: 55-64.
54. Garson JA, Grant PR, Ayliffe U, Ferns RB, Tedder RS, (2005) Real-time PCR quantitation of hepatitis B virus DNA using automated sample preparation and murine cytomegalovirus internal control. Journal of virological methods 126: 207-213.
55. Sung JJ, Tsui SK, Tse CH, Ng EY, Leung KS, et al. (2008) Genotype-specific genomic markers associated with primary hepatomas, based on complete genomic sequencing of hepatitis B virus. Journal of virology 82: 3604-3611.
56. Ballard AL, Boxall EH, (1999) Assessing the infectivity of hepatitis B carriers. Communicable disease and public health/PHLS 2: 178-183.
57. Gunther S, Li BC, Miska S, Kruger DH, Meisel H, et al. (1995) A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. Journal of virology 69: 5437-5444.
58. Takahashi K, Akahane Y, Hino K, Ohta Y, Mishiro S, (1998) Hepatitis B virus genomic sequence in the circulation of hepatocellular carcinoma patients: comparative analysis of 40 full-length isolates. Archives of virology 143: 2313-2326.
59. Li JH, Lao XQ, Tillmann HL, Rowell J, Patel K, (2010) Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infection. Hepatology 51: 1904-1911.
60. Burland TG, (2000) DNASTAR's Lasergene sequence analysis software. Methods in molecular biology 132: 71-91.
61. Thompson JD, Gibson TJ, Higgins DG, (2002) Multiple sequence alignment using ClustalW and ClustalX. Current protocols in bioinformatics/editoral board, Andreas D Baxevanis [et al] Chapter 2: Unit 2 3.
62. Hall TA, (1999) BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 41: 91-98.
63. Swofford DL, (2003) PAUP*. Phylogenetic Analysis Using Parsimony (*and Other Methods). Version 4. Sinauer Associates, Sunderland, Massachusetts.
64. Chun HM, Roediger MP, Hullsiek KH, Thio CL, Agan BK, (2012) Hepatitis B virus coinfection negatively impacts HIV outcomes in HIV seroconverters. The Journal of infectious diseases 205: 185-193.
65. Matthews GV, Manzini P, Hu Z, Khabo P, Maja P, (2011) Impact of lamivudine on HIV and hepatitis B virus-related outcomes in HIV/hepatitis B virus individuals in a randomized clinical trial of antiretroviral therapy in southern Africa. AIDS 25: 1727-1735.
66. Peters PJ, Marston BJ, (2012) Preventing deaths in persons with HIV/hepatitis B virus coinfection: a call to accelerate prevention and treatment efforts. The Journal of infectious diseases 205: 166-168.
67. Qu LS, Liu TT, Jin F, Guo YM, Chen TY, (2011) Combined pre-S deletion and core promoter mutations related to hepatocellular carcinoma: A nested case-control study in China. Hepatology research: the official journal of the Japan Society of Hepatology 41: 54-63.
68. Zhu Y, Jin Y, Guo X, Bai X, Chen T, (2010) Comparison study on the complete sequence of hepatitis B virus identifies new mutations in core gene associated with hepatocellular carcinoma. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 19: 2623-2630.
69. Truong BX, Yano Y, Seo Y, Phuong TM, Tanaka Y, (2007) Variations in the core promoter/pre-core region in HBV genotype C in Japanese and Northern Vietnamese patients. Journal of medical virology 79: 1293-1304.
70. Huy TT, Ushijima H, Quang VX, Ngoc TT, Hayashi S, (2004) Characteristics of core promoter and precore stop codon mutants of hepatitis B virus in Vietnam. Journal of medical virology 74: 228-236.
71. Liu WC, Phiet PH, Chiang TY, Sun KT, Hung KH, (2007) Five subgenotypes of hepatitis B virus genotype B with distinct geographic and virological characteristics. Virus research 129: 212-223.
72. Rauch A, Kutalik Z, Descombes P, Cai T, Di Iulio J, (2010) Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 138: 1338-1345, 1345 e1331-1337.
73. Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, (2009) IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nature genetics 41: 1100-1104.
74. Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, (2009) Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nature genetics 41: 1105-1109.